Clinical Trial Update: Evaluation of an Oral Cannabidiol (CBD)-Terpene Formulation on Sleep Physiology in Participants With Insomnia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an oral cannabidiol-terpene formulation for sleep physiology in adults with insomnia; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• CBD-terpene formulation (cannabidiol (CBD) with terpenes)

Snippet

Sponsor: Defined Research | Conditions: Insomnia | Phase 2 | Status: COMPLETED | Results posted: 2025-09-11